GlassScriptPhysician profile
Sheela Chockalingam
NPI 1306208475
$15,147.98
in general payments reported to CMS, 2019-2025
31 companies · $2,311 in 2025
The $2,311 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,965 · 2020: $746 · 2021: $3,436 · 2022: $4,633 · 2023: $1,407 · 2024: $651 · 2025: $2,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,080 · Travel and Lodging: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,079.52 |
| Travel and Lodging | $1,288.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,889.61 | 2019-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Actishield |
| Smith+Nephew, INC. | $1,905.39 | 2020-2025 | Pico, Grafix, Collagenase Santyl |
| Treace Medical Concepts, INC. | $1,797.92 | 2022-2025 | |
| Arthrex, INC. | $1,520.00 | 2021 | |
| Paragon 28, INC. | $1,252.04 | 2019-2025 | Mtp |
| Musculoskeletal Transplant Foundation INC. | $376.84 | 2020 | |
| Triad Life Sciences INC. | $348.96 | 2022 | |
| Organogenesis INC. | $345.17 | 2022-2025 | Puraply, Apligraf |
| Paratek Pharmaceuticals, INC. | $198.11 | 2022-2025 | Nuzyra |
| Convatec INC. | $192.28 | 2023 | |
| Nevro Corp. | $189.01 | 2021-2024 | Senza |
| Horizon Therapeutics Plc | $163.46 | 2021-2023 | Krystexxa |
| Anika Therapeutics, INC. | $157.64 | 2022 | |
| Osteomed LLC | $110.69 | 2019 | |
| Great Lakes Orthopedics | $100.21 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $79.73 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $59.08 | 2023-2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $55.43 | 2025 | Motoband, Minibunion |
| Lifenet Health | $52.06 | 2024-2025 | Theragenesis Wound Matrix |
| Medtronic, INC. | $43.22 | 2022-2023 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $41.95 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Averitas Pharma INC. | $41.43 | 2024-2025 | Qutenza |
| Abbvie INC. | $36.75 | 2022-2023 | Dalvance |
| Ibsa Pharma INC. | $34.92 | 2023-2024 | Tirosint, Licart, Tirosint |
| Nabriva Therapeutics, Plc | $31.61 | 2022 | |
| Urgo Medical North America, LLC | $30.72 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Orthofix Medical, INC. | $26.63 | 2022 | |
| Music City Medical Technologies, LLC | $17.63 | 2025 | |
| Abbott Laboratories | $17.46 | 2024 | Proclaim |
| Kerecis Limited | $16.59 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheela Chockalingam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.